Washington University School Of Medicine
Clinical trials sponsored by Washington University School Of Medicine, explained in plain language.
-
Custom-Made vaccine targets aggressive brain tumors in early trial
⭐️ VACCINE ⭐️ OngoingThis early-phase study tested a personalized DNA vaccine in 9 people with a fast-growing type of brain cancer called glioblastoma. The vaccine was custom-made for each patient based on their tumor's unique genetic mutations. The main goals were to see if the vaccine was safe, pos…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 02:48 UTC
-
DNA vaccine aims to train body to fight breast cancer
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests whether a DNA vaccine targeting mammaglobin-A (a protein found on breast cancer cells) is safe and can boost the immune system against cancer. About 27 women with ER+, HER2- breast cancer will receive the vaccine while undergoing standard hormone ther…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:54 UTC
-
New pill takes on rare skin cancer in early trial
Disease control OngoingThis early-phase study tests a new drug called tulmimetostat (DZR123) in 24 adults with advanced mycosis fungoides or Sézary syndrome—rare types of skin lymphoma—who have already tried at least one other treatment. The main goals are to check the drug's safety and find the best d…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:05 UTC
-
New cocktail shows promise for incurable head and neck cancer
Disease control OngoingThis study tests a three-drug combination (cisplatin, nab-paclitaxel, and cetuximab) in 74 people with head and neck cancer that cannot be cured. The goal is to see if this mix works better and causes fewer side effects than the standard treatment. Participants have advanced or r…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New combo therapy aims to boost pancreatic cancer survival
Disease control OngoingThis early-phase trial tests a new drug (TTI-101) combined with targeted radiation for people with pancreatic cancer that cannot be removed by surgery right away. The goal is to see if the combination is safe and can help keep the cancer from growing for longer. About 5 participa…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
Could a drug delay Alzheimer's in High-Risk families?
Disease control OngoingThis study tests whether certain drugs can slow memory loss and thinking problems in people who have a genetic mutation that causes Alzheimer's disease. About 490 adults aged 18 to 80 who either know they carry the mutation or are from families with the mutation will receive eith…
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:04 UTC
-
New combo shows promise for tough head and neck cancers
Disease control OngoingThis study tested a combination of two drugs—nab-paclitaxel (a chemotherapy) and nivolumab (an immunotherapy)—in 46 people with advanced head and neck cancer that had stopped responding to a prior immunotherapy. The goal was to see if the combo could shrink tumors or slow the dis…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New combo therapy shows promise for rare, aggressive skin cancer
Disease control OngoingThis study tests a treatment plan for people with a rare and aggressive skin cancer called cutaneous angiosarcoma. Participants first receive a chemotherapy drug (paclitaxel) alone, then the same drug combined with radiation therapy, followed by surgery to remove the cancer. The …
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:03 UTC
-
New drug combo aims to keep relapsed myeloma in check after second transplant
Disease control OngoingThis study tests whether a combination of three drugs (elotuzumab, pomalidomide, and dexamethasone) given after a second stem cell transplant can help people with multiple myeloma that has come back. The goal is to keep the cancer under control for as long as possible. The study …
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:01 UTC
-
New combo targets Hard-to-Treat lung cancers after first therapy fails
Disease control OngoingThis study tests a new three-drug combination (ADI-PEG 20, gemcitabine, and docetaxel) in people with small cell or non-small cell lung cancer whose disease has worsened after initial treatment. The first part of the study finds the safest dose, and the second part checks how wel…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:01 UTC
-
New combo therapy aims to boost immune attack on uterine cancer
Disease control OngoingThis early-stage study tests adding an immunotherapy drug (TSR-042) to standard radiation for people with endometrial cancer that cannot be removed by surgery. The goal is to see if the combination is safe and can help the immune system fight the cancer more effectively. About 10…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:01 UTC
-
New drug combo shows promise in lymphoma study
Disease control OngoingThis study tests a combination of two drugs, mosunetuzumab and polatuzumab vedotin, in people with untreated follicular lymphoma. The drugs work together to help the immune system find and kill cancer cells. The goal is to see how many patients have their tumors completely disapp…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:01 UTC
-
New combo therapy aims to stop lung cancer in its tracks
Disease control OngoingThis study tests whether adding a new drug (APL-101) to standard treatment (osimertinib) can better control advanced EGFR-mutated lung cancer. About 27 adults with metastatic non-small cell lung cancer who have been on osimertinib for 8-12 weeks without progression will receive t…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 03:00 UTC
-
Can two old drugs turn back the clock on aging in depression and schizophrenia?
Disease control OngoingThis study tests whether a combination of two drugs, dasatinib and quercetin, can safely slow down accelerated aging in older adults with treatment-resistant depression or schizophrenia. The drugs are known to remove aging cells from the body. The study involves 40 participants a…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:59 UTC
-
New hope for lung transplant patients: blood therapy may slow deadly airway disease
Disease control OngoingThis study tests a treatment called extracorporeal photopheresis (ECP) for lung transplant patients who develop bronchiolitis obliterans syndrome (BOS), a condition that causes progressive lung damage. The treatment involves filtering the patient's blood, treating it with light a…
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:58 UTC
-
New hope for abdominal cancer patients: targeted chemo combo shows promise
Disease control OngoingThis early-phase study tests a new way to deliver chemotherapy directly into the abdomen for people whose appendix or colon cancer has spread to the lining of the belly. After surgery to remove visible tumors, participants receive a combination of drugs: one given through a port …
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:58 UTC
-
Could a simple pill boost CAR T-Cell staying power against blood cancers?
Disease control OngoingThis early-phase study tests whether adding the drug duvelisib after CAR T-cell therapy can help the immune cells survive longer and fight non-Hodgkin lymphoma or acute lymphocytic leukemia more effectively. About 42 adults who are eligible for approved CAR T-cell treatments will…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:58 UTC
-
Phone app fights depression and boosts HIV drug adherence in ugandan teens
Disease control OngoingThis study tests a mobile app called Suubi-Mhealth for Ugandan teens aged 14-17 who have both HIV and depression. The app uses cognitive-behavioral therapy (CBT) to improve mood and help them stick to their HIV medication. Researchers will track changes in depression scores and m…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:56 UTC
-
New drug combo shows promise in fighting tough head and neck cancers
Disease control OngoingThis study tests whether adding ramucirumab to the standard immunotherapy pembrolizumab works better than pembrolizumab alone for people with advanced head and neck cancer that has come back or spread. The trial includes 37 adults whose tumors have a specific marker (PD-L1 positi…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:55 UTC
-
Group prenatal care may lower depression and preterm birth risk for black mothers
Disease control OngoingThis study tests a group prenatal care program called EleVATE GC for African-American women at high risk for postpartum depression. The program aims to reduce depression, preterm birth, and low birthweight by providing support and addressing stress. About 416 pregnant women will …
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:55 UTC
-
New hope for pregnant women: nutrition and therapy may boost baby brain health and prevent early birth
Disease control OngoingThis study tests whether a special food supplement with extra omega-3s and choline can help undernourished pregnant women carry their babies longer and improve their babies' brain development. It also tests a counseling program to reduce depression during and after pregnancy. Abo…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:55 UTC
-
New drug combo shows promise in early sarcoma trial
Disease control OngoingThis early-phase study tests a new drug (ADI-PEG 20) combined with chemotherapy and radiation before surgery for soft tissue sarcoma. The goal is to find the safest dose and see if it helps shrink tumors. Only 6 people are enrolled so far, and the study is actively monitoring for…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:55 UTC
-
Money and family therapy may curb child behavior problems
Disease control OngoingThis study tests whether helping families with money and parenting skills can improve behavior in children with oppositional defiant disorder or conduct disorder. About 900 children aged 10-14 and their caregivers in Uganda will be split into three groups: one gets financial help…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:55 UTC
-
Could 'Zombie Cell' cleaners slow Alzheimer's? new trial underway
Disease control OngoingThis study tests whether senolytic drugs—medicines that clear out aging 'zombie' cells—are safe and workable for people with early Alzheimer's or mild memory problems. About 48 adults aged 60 and older with elevated tau protein will receive either the drug or a placebo. The main …
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:54 UTC
-
Can money skills and peer support help teens beat HIV? uganda study aims to find out
Disease control OngoingThis study tests four different programs to see which combination best helps young people (ages 11-17) with HIV in Uganda keep the virus under control. The programs include financial literacy training, savings accounts, a cartoon-based adherence and stigma reduction guide, and me…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:53 UTC
-
New drug cocktail shows promise against rare sarcoma
Disease control OngoingThis study tests whether combining the targeted drug cabozantinib with two immunotherapy drugs (nivolumab and ipilimumab) can shrink tumors in people with metastatic soft tissue sarcoma that has not responded to prior treatments. About 105 participants will receive the combinatio…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:53 UTC
-
New drug combo shows promise for Hard-to-Treat brain cancer
Disease control OngoingThis early-phase study tests a combination of two drugs (acalabrutinib and durvalumab) for people with primary central nervous system lymphoma, a rare brain cancer. The study includes up to 25 patients whose cancer has returned or who cannot take standard high-dose chemotherapy. …
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:53 UTC
-
New drug cocktail aims to keep myeloma in check after transplant
Disease control OngoingThis study tests a three-drug combination (ixazomib, lenalidomide, and dexamethasone) given after a stem cell transplant to people with multiple myeloma. The goal is to see if this treatment can keep the cancer away longer. After four cycles, participants receive one of two maint…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:52 UTC
-
Milder stem cell transplant offers hope for kids with rare immune diseases
Disease control OngoingThis study tests a less intense stem cell transplant for children and young adults up to age 28 with various immune system disorders. The goal is to see if a milder pre-transplant treatment can help donor cells take hold with fewer serious side effects. The study tracks engraftme…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:52 UTC
-
New drug cocktail shows promise for hard-to-treat head and neck cancer
Disease control OngoingThis study tests a combination of three drugs (olaparib, pembrolizumab, and carboplatin) as a first treatment for people with head and neck cancer that has come back or spread. The goal is to see if this mix works better than the current standard therapy. About 30 adults with inc…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:51 UTC
-
Custom DNA vaccine takes on deadly brain cancer in early trial
Disease control OngoingThis early-phase study tests a personalized DNA vaccine made from each patient's unique tumor mutations, given together with an immunotherapy drug (retifanlimab) that helps the immune system attack cancer. The trial enrolls 27 adults with a fast-growing type of glioblastoma that …
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
New hope against river blindness: safer drug combos tested
Disease control OngoingThis study tests whether combining different drugs can safely and effectively treat onchocerciasis (river blindness) in 300 adults. Participants first receive ivermectin to clear young worms from skin and eyes, then get one of four drug combinations. Researchers will monitor side…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New drug duo shows promise in shrinking breast tumors before surgery
Disease control OngoingThis study tests whether adding a targeted drug (PD 0332991) to standard hormone therapy (anastrozole) can better stop breast cancer cell growth before surgery. It involves 84 women with early-stage ER+ HER2- breast cancer. The goal is to see if the combination leads to more comp…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Immunotherapy-Chemo combo shows promise for aggressive breast cancer
Disease control OngoingThis study tests whether adding the immunotherapy drug nivolumab to standard chemotherapy before surgery can help the immune system fight triple-negative breast cancer more effectively. About 15 people with early-stage (stage II or III) triple-negative breast cancer will receive …
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Double transplant strategy aims to tame tough lymphoma
Disease control OngoingThis study tests a two-step transplant approach for people with high-risk non-Hodgkin's lymphoma. First, patients receive their own stem cells, followed by a donor transplant to boost long-term disease control. The goal is to improve survival and manage the cancer, not to cure it…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for rare, aggressive cancer: cabozantinib trial shows promise
Disease control OngoingThis study tests the drug cabozantinib in 35 adults with high-grade neuroendocrine tumors that have worsened after at least one prior treatment. The goal is to see if cabozantinib can shrink tumors or slow disease progression. Participants take the drug orally, and researchers tr…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
Experimental immune boost shows promise for brain cancer patients
Disease control OngoingThis study tests a drug called rhIL-7-hyFc in people with high-grade glioma (a type of brain tumor) whose immune cell levels drop after standard radiation and chemotherapy. The goal is to see if the drug can safely increase lymphocyte counts, which help fight infections and may i…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Could group prenatal care help moms with diabetes?
Disease control OngoingThis study tests whether attending prenatal care in a group setting helps women with type 2 or gestational diabetes control their blood sugar and manage weight after giving birth. About 117 pregnant women will be randomly assigned to either group or traditional one-on-one care. R…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug combo shows promise for High-Risk MDS patients
Disease control OngoingThis study tests a chemotherapy drug called CPX-351 in 20 adults aged 18-70 with high-risk myelodysplastic syndrome (MDS) who are eligible for a stem cell transplant. The main goal is to see if the drug is safe and tolerable at two different dose levels. Researchers will also tra…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New combo therapy shows promise for Tough-to-Treat lymphoma
Disease control OngoingThis early-phase study tests whether adding the drug mosunetuzumab to standard chemotherapy is safe and effective for people with aggressive B-cell lymphoma that has returned or not responded to prior treatment. About 24 participants will receive one of two chemotherapy backbones…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New study offers hope for asthma patients who forget their daily inhalers
Disease control OngoingThis study looks at a different way to use asthma inhalers for people who often forget to take their daily maintenance inhaler. Instead of using a daily inhaler, participants will use a combination inhaler only when they have symptoms. The goal is to see if this approach helps pe…
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Can a nutrient in eggs keep malnourished kids from getting worse?
Disease control OngoingThis study tests whether adding choline (a nutrient found in eggs and meat) to standard food supplements helps children aged 6-59 months with moderate acute malnutrition avoid worsening to severe acute malnutrition. About 1,500 children in Malawi will receive either standard or c…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Supercharged immune cells aim to beat back tough leukemia
Disease control OngoingThis study tests whether giving patients with hard-to-treat acute myeloid leukemia (AML) specially trained immune cells (memory-like NK cells) after a half-matched donor stem cell transplant can keep the cancer away longer. About 60 adults whose leukemia did not respond to standa…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Nerve transfers restore hand function in tetraplegia patients
Disease control OngoingThis study tests whether nerve transfer surgery can improve hand and arm function in 70 people with complete spinal cord injuries who have no hand function. Participants must be 18-65 years old, within 3 years of injury, and have stable paralysis. The surgery aims to restore move…
Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:51 UTC
-
Which shoulder surgery is better? new study aims to find out
Disease control ENROLLING_BY_INVITATIONThis study compares two types of shoulder replacement surgery for people with glenohumeral osteoarthritis: a partial replacement using a special carbon material (hPYC) and a total replacement (aTSA). 74 participants will be randomly assigned to one surgery and followed for 10 yea…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Can a new drug stop inherited Alzheimer's before it starts?
Disease control OngoingThis study tests the drug lecanemab in 40 people who have a gene mutation that causes early-onset Alzheimer's. The goal is to see if removing amyloid plaques from the brain can delay or slow memory loss and other symptoms. Participants previously received another experimental dru…
Phase: PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
New inhaler strategy could help teens with asthma who avoid daily meds
Disease control OngoingThis study looks at a new way for teens with asthma to use their inhaler only when they have symptoms, instead of every day. Many teens skip their daily maintenance inhalers, which can lead to hospital visits. The goal is to see if this symptom-driven approach improves how often …
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 20, 2026 12:07 UTC
-
New radiation technique aims to safely target aggressive prostate cancer
Disease control OngoingThis study tests a new way to deliver radiation to the prostate and nearby lymph nodes in men with high-risk or unfavorable intermediate-risk prostate cancer. The approach uses MRI to find the main tumor and gives it an extra dose of radiation. The goal is to see if this method i…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Larynx cancer patients may avoid unnecessary neck radiation
Disease control OngoingThis study tests whether it is safe to reduce or skip radiation on one or both sides of the neck that show no signs of cancer after surgery. The goal is to lessen side effects from radiation without increasing the chance of cancer coming back. About 74 adults with larynx or relat…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Money smarts may boost HIV med adherence in ugandan teens
Disease control OngoingThis study tests whether helping HIV-positive teenagers in Uganda save money and start small income-generating projects can improve their adherence to HIV medication. 702 adolescents aged 10-16 are participating. The goal is to see if economic stability can be a key ingredient in…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
New combo therapy targets tough pancreatic cancer
Disease control OngoingThis study tests whether adding a drug called defactinib to targeted radiation therapy can help control advanced pancreatic cancer better than radiation alone. About 42 people with locally advanced pancreatic cancer that cannot be removed by surgery will take part. The main goal …
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Engineered donor cells take aim at Hard-to-Treat blood cancers
Disease control OngoingThis early-phase study tests a new type of CAR T-cell therapy made from donor cells (WU-CART-007) for people with CD7-positive blood cancers, including acute myeloid leukemia and T-cell lymphoma that have not responded to standard treatments. The therapy is designed to target and…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New strategy aims to keep HIV-Positive teens in treatment
Disease control OngoingThis study tests ways to help teens and young adults with HIV stay engaged in their care. Researchers in Kenya will try text message reminders, peer support, and small cash rewards to prevent missed appointments and improve viral suppression. The goal is to find the most effectiv…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 18, 2026 12:03 UTC
-
New triple therapy hopes to shrink lung tumors after other treatments fail
Disease control OngoingThis study tests a combination of three drugs (zimberelimab, domvanalimab, and etrumadenant) in 30 adults with advanced non-small cell lung cancer who have already received immunotherapy. The goal is to see if the triple therapy can shrink tumors or stop them from growing. Partic…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Could a new combo drug delay Alzheimer's in High-Risk families?
Disease control OngoingThis study tests whether an experimental drug (E2814) combined with lecanemab can slow Alzheimer's disease in people who carry a genetic mutation that causes it. About 197 adults aged 18-80 with mild or no symptoms will receive either the drug or a placebo for up to 4 years. Rese…
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 18, 2026 12:02 UTC
-
Custom-Made vaccine takes on tough lung cancer
Disease control OngoingThis study tests a personalized vaccine (made from each patient's unique tumor markers) combined with the immunotherapy drug durvalumab in people with extensive-stage small cell lung cancer. The goal is to see if this combination is safe and can slow cancer growth. Only 6 partici…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Weight-loss drug plus IUD aims to save uterus in women at cancer risk
Disease control TerminatedThis study was designed to see if combining a weight-loss drug (semaglutide) with a hormone-releasing IUD could help premenopausal women with obesity and a precancerous uterine condition keep their uterus and avoid cancer. It planned to enroll women who wanted to preserve their f…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 11, 2026 20:52 UTC
-
Could a single radiation dose be as good as five for breast cancer?
Disease control OngoingThis study compares a single dose of radiation to five doses after breast cancer surgery for people with very early-stage breast cancer. The goal is to see if one dose works just as well at preventing the cancer from coming back, while also reducing side effects and improving qua…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
New hope for chronic DVT sufferers: catheter therapy aims to reduce leg pain and swelling
Disease control OngoingThis study looks at whether a catheter-based procedure can help people with long-term leg pain, swelling, or ulcers caused by old blood clots in the deep veins. About 225 adults with disabling symptoms will either get the procedure plus standard care or standard care alone. The g…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated May 06, 2026 16:15 UTC
-
New three-step combo therapy targets tough head and neck cancers
Disease control OngoingThis study tests a three-step treatment plan for people with a type of head and neck cancer not linked to HPV. First, patients receive a drug called palbociclib before standard chemoradiation, then they get more palbociclib after treatment. The goal is to see if this approach hel…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC
-
Mothers and daughters team up to fight HPV in nigeria
Prevention OngoingThis study tests a new community-designed campaign to help prevent HPV, a virus that can cause cancer. About 1,838 mothers and daughters in Nigeria will take part. The campaign encourages girls to get the HPV vaccine and mothers to do a simple self-test for HPV, aiming to make pr…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated May 26, 2026 02:55 UTC
-
Bone drug may cut breast cancer risk in women with dense breasts
Prevention OngoingThis study tests whether denosumab, a drug used for bone health, can reduce breast density in premenopausal women with dense breasts. High breast density is a known risk factor for breast cancer. The trial involves 210 women and aims to see if lowering density could open new ways…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated May 22, 2026 14:04 UTC
-
New program aims to stop child abuse before it starts
Prevention OngoingThis study tests whether giving extra help and resources to families of newborns who are at higher risk can prevent child abuse and neglect. About 150 families are randomly assigned to receive either standard care or an enhanced program that connects them to services like home vi…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated May 20, 2026 11:54 UTC
-
Cochlear implant outshines hearing aid for kids with One-Sided deafness
Symptom relief OngoingThis study compares how well children with hearing loss in one ear (asymmetric hearing loss or single-sided deafness) can hear with a cochlear implant versus a hearing aid. About 80 children aged 4 to 14 will be tested before and after getting the implant. The goal is to see if t…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 26, 2026 03:01 UTC
-
Tuning in to calm: music may soothe kids after surgery
Symptom relief OngoingThis study tests whether playing a child's favorite music before and after ear tube surgery can reduce confusion and agitation when they wake up. About 160 children aged 3 to 9 will be randomly assigned to hear personalized music or standard care. The goal is to see if music can …
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 26, 2026 02:59 UTC
-
Brain training boosts memory in Parkinson's patients?
Symptom relief OngoingThis study tests two types of memory training for people with Parkinson's disease who also have mild memory problems. 120 participants will be randomly assigned to one of two training programs and complete 8 sessions over 8 weeks. The goal is to see if these programs improve thei…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 26, 2026 02:57 UTC
-
Could a common Alzheimer's drug ease Poison-Induced delirium?
Symptom relief TerminatedThis study tests whether rivastigmine, a drug used for Alzheimer's, can help people with severe confusion and agitation caused by anticholinergic poisoning. About 42 participants aged 10 and older will receive either rivastigmine or a placebo. The goal is to see if rivastigmine s…
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 26, 2026 02:53 UTC
-
Proton beam therapy may ease side effects for esophageal cancer patients
Symptom relief OngoingThis study looks at whether proton beam therapy, a precise form of radiation, causes fewer severe side effects than standard radiation for people with esophageal cancer. About 22 patients with stage II or III esophageal cancer will receive proton therapy, and researchers will tra…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 26, 2026 02:51 UTC
-
School counselors deliver new hope for kids' emotional health
Symptom relief ENROLLING_BY_INVITATIONThis study tests a 6-8 week therapy program called THRIVE that helps young children (ages 3-7) and their caregivers build emotional skills. School counselors deliver the program via video or in school. The goal is to reduce children's behavioral problems and improve caregivers' w…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 26, 2026 02:51 UTC
-
New program aims to break cycle of trauma in refugee families
Symptom relief OngoingThis study tests a program to help teens born in the U.S. to refugee parents deal with emotional and behavioral problems like PTSD, depression, and anxiety. About 308 teens and their parents will join weekly group sessions and virtual peer mentoring to learn coping skills. Resear…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 22, 2026 14:05 UTC
-
Robots vs. scalpels: which knee surgery brings faster pain relief?
Symptom relief OngoingThis study looks at whether robot-assisted knee replacement surgery leads to better pain relief and recovery than traditional surgery. About 95 adults with knee osteoarthritis will have one type of surgery and track their pain and opioid use for weeks after. The goal is to see wh…
Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Laughing gas may curb suicidal urges in depressed patients
Symptom relief ENROLLING_BY_INVITATIONThis study tests whether inhaling nitrous oxide (laughing gas) can quickly reduce suicidal thoughts in adults hospitalized for depression. About 50 participants will receive either nitrous oxide or a placebo gas, plus their usual treatment. The goal is to see if this approach is …
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
New pain drug vs. catheter: which works better for shoulder surgery?
Symptom relief ENROLLING_BY_INVITATIONThis study tests if a single dose of ZYNRELEF applied during shoulder replacement surgery can reduce the need for strong painkillers compared to a nerve block with a catheter. About 86 adults having their first shoulder replacement will be randomly assigned to one of the two pain…
Phase: PHASE4 • Sponsor: Washington University School of Medicine • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC
-
Lung cancer showdown: surgery vs. radiation – which works better?
Knowledge-focused OngoingThis study compares two standard treatments for stage I non-small cell lung cancer: surgery and stereotactic body radiation therapy (SBRT). About 446 patients are being followed for up to 3 years to see which treatment leads to better disease-free survival and quality of life. Th…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 03:02 UTC
-
Lab test may predict chemo success for blood cancer patients
Knowledge-focused OngoingThis study looks at whether a lab test can predict how well chemotherapy will work for people with acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). Researchers will take blood samples before treatment and test them in the lab to see if the results match how patien…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 03:01 UTC
-
Brain breathing test: how your blood vessels react to CO2
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to learn how brain blood flow and metabolism differ between healthy adults and those with brain blood vessel disease. Researchers will use MRI scans and a special mask to control the air participants breathe, measuring how the brain's blood vessels expand and cont…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 03:01 UTC
-
Should you know your Alzheimer's odds? new study finds out
Knowledge-focused OngoingThis study looks at what happens when healthy older adults (65+) are told their personal risk of developing Alzheimer's dementia within five years. Researchers are measuring changes in mood, thinking skills, and distress after participants receive their risk results. The goal is …
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 03:01 UTC
-
New imaging and blood markers could personalize Crohn's care
Knowledge-focused OngoingThis study looks at 112 people with small bowel Crohn's disease who are starting a new biologic therapy. Researchers use MRI scans and blood protein tests to see if early changes can predict who will be in remission without steroids after one year. The goal is to help doctors cho…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:58 UTC
-
New recovery recipe may get kids home sooner after bladder surgery
Knowledge-focused OngoingThis study looks at whether a special recovery plan (called ERAS) helps children and young adults heal faster after bladder reconstruction surgery. The plan includes steps to better manage pain and get patients out of the hospital sooner. Researchers will compare results from 85 …
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:57 UTC
-
Brain scans aim to predict dementia in Parkinson's patients
Knowledge-focused OngoingThis study uses a special brain scan called PIB PET to look at different types of dementia in people with Parkinson's disease. The goal is to find out who might develop dementia and what is causing it. Researchers will study 320 participants to better understand the link between …
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:57 UTC
-
Can pictures make research consent clearer?
Knowledge-focused OngoingThis study tests whether using a visual consent form with pictures and simple language helps patients better understand research studies. Researchers will compare the standard consent process to a new visual version in studies on cancer and Alzheimer's disease. About 266 patients…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:57 UTC
-
Vaccine shield check: scientists probe JYNNEOS protection duration
Knowledge-focused OngoingThis study looks at how long the JYNNEOS vaccine (used against smallpox and monkeypox) stays effective. Researchers will measure immune responses in the blood, lungs, skin, and bone marrow of 20 healthy adults aged 18-60 who have never had the vaccine or monkeypox before. The goa…
Phase: EARLY_PHASE1 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:55 UTC
-
New PET tracers aim to sharpen Alzheimer's diagnosis
Knowledge-focused OngoingThis study tests three new radioactive dyes (tracers) for PET scans to see how well they detect tau protein buildup in the brains of people with Alzheimer's disease compared to healthy older adults. About 38 participants will receive up to three different scans to find which trac…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:53 UTC
-
Gene test could sharpen leukemia risk forecasts
Knowledge-focused OngoingThis study looks at whether checking for leukemia-related gene mutations after initial treatment can help predict which patients will stay cancer-free. About 107 adults aged 18-60 with intermediate-risk acute myeloid leukemia (AML) are being followed. The goal is to see if those …
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:53 UTC
-
Gene hunt: could your DNA predict prostate Cancer's spread?
Knowledge-focused OngoingThis study follows nearly 2,000 men with newly diagnosed prostate cancer to see if certain genes make the cancer more likely to spread. Researchers collect blood or tissue samples and track health outcomes over time. The goal is to better understand genetic risk factors, not to t…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC
-
Healthy kids help unlock secrets of ear stimulation on brain waves
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how a mild electrical stimulation of the ear (called taVNS) affects brain waves in 10 healthy children. The goal is to see if it is safe and tolerable, and whether it changes the EEG. Children will receive one 30-minute session while their heart rate, oxygen l…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:48 UTC
-
Can adaptive radiotherapy shield ovaries in young cancer patients?
Knowledge-focused OngoingThis study explores whether a special type of radiation therapy can protect the ovaries of young women (ages 18-50) undergoing pelvic radiation for cancers like uterine, rectal, or cervical cancer. The goal is to see if doctors can consistently see the ovaries on daily scans and …
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 26, 2026 02:47 UTC
-
Teen migraine mystery: do hormones make pain worse?
Knowledge-focused OngoingThis study explores how changing sex hormone levels during puberty relate to migraine pain and sensitivity in adolescents aged 11 to 15. Researchers will measure pain responses and hormone levels in both teens with migraines and healthy controls. The goal is to better understand …
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC
-
Which diet wins? study tests mediterranean, Low-Carb, and Plant-Based plans
Knowledge-focused OngoingThis study looks at why some people with obesity develop health problems like diabetes and heart disease while others don't. Researchers will compare three popular weight loss diets—Mediterranean, low-carb, and very-low-fat plant-based—in 180 people with obesity. The goal is to u…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC
-
New brain scan could reveal hidden inflammation in parkinson disease
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether small amounts of brain inflammation contribute to movement and thinking problems in people with Parkinson disease. Researchers will use a special PET scan with an experimental tracer to measure inflammation in the brain. The study includes 80 volunteer…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 14:01 UTC
-
AI-Powered alerts aim to prevent Post-Surgery complications
Knowledge-focused TerminatedThis study planned to test whether giving doctors machine-learning risk alerts could reduce serious complications after surgery, like unplanned ICU stays or kidney injury. It was designed for high-risk patients, but the study was withdrawn before any participants were enrolled. N…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC
-
Personalized risk feedback may improve lung cancer screening and smoking cessation
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests whether giving doctors and patients a personalized risk report (based on clinical or genetic information) increases the number of people who get screened for lung cancer and receive help to quit smoking. About 915 patients and their primary care doctors are takin…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Brain scans reveal which radiation spots harm memory
Knowledge-focused OngoingThis study follows 71 people with glioma (a type of brain tumor) to see how radiation therapy affects their thinking skills over time. Researchers use special brain scans to map which brain networks are most sensitive to radiation damage. The goal is to learn how to protect these…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
Sleep disorder study could pave way for Parkinson's prevention
Knowledge-focused ENROLLING_BY_INVITATIONThis study enrolls 500 adults with REM sleep behavior disorder (RBD) and healthy volunteers to track early signs of brain diseases like Parkinson's and Lewy body dementia. Participants undergo tests of thinking, movement, smell, and vision. The goal is to prepare for future clini…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 22, 2026 13:51 UTC
-
Pregnant? your sleep could shape your heart health
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at sleep health in 50 pregnant women with low income. Researchers will use a home sleep test and a wrist monitor to measure sleep. They want to see how sleep relates to heart health and social factors. The goal is to create better sleep guidelines and treatments …
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:57 UTC
-
Vitamin D's secret role in blood pressure revealed?
Knowledge-focused OngoingThis study looks at how vitamin D levels might influence blood pressure in people with type 2 diabetes. Researchers will collect blood samples from 40 participants to see if certain immune cells (monocytes) trigger a hormone that raises blood pressure. The goal is to better under…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
What predicts a good hip surgery outcome? researchers investigate
Knowledge-focused OngoingThis study aims to find out which patient traits, disease features, and surgical factors lead to better results after hip surgery for femoroacetabular impingement (FAI). Researchers are following 747 young adults and military personnel who had hip arthroscopy. They will use surve…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
Scientists hunt for hidden signs of muscle pain in new imaging study
Knowledge-focused OngoingThis study aims to find new ways to measure myofascial pain using advanced imaging like MRI. Researchers will compare 52 participants—some with chronic muscle pain and some healthy—to see if imaging can spot differences in tissue stiffness, blood flow, and inflammation. The goal …
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
Scientists dive deep into bone marrow to unlock vaccine memory secrets
Knowledge-focused OngoingThis study aims to understand how the immune system remembers vaccines over time. Healthy adults will receive four FDA-approved vaccines at once, and researchers will track their immune responses through blood and bone marrow samples for up to two years. The goal is to learn more…
Phase: PHASE4 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC
-
Study reveals how diet or surgery reshapes meal processing
Knowledge-focused OngoingThis study looks at how the body handles carbohydrates and fats after eating, in African American and white adults with obesity. Participants will eat a standard or low-carb meal before and after losing about 16-18% of their weight through a low-calorie diet or gastric bypass sur…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 19, 2026 12:00 UTC
-
Online prep program for head and neck surgery pulled before starting
Knowledge-focused TerminatedThis study aimed to see if a personalized online education program could help patients and caregivers feel more prepared before and after major head and neck surgery. It also hoped to reduce hospital readmissions and unplanned visits. However, the study was withdrawn before any p…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 19, 2026 11:47 UTC
-
Can money skills help orphaned teens avoid HIV? uganda study aims to find out.
Knowledge-focused OngoingThis study compares two methods of rolling out a program called Bridges, which teaches financial skills and provides support to young people ages 11-17 who lost parents to AIDS. About 1,440 students from 48 schools in Uganda will take part. The goal is to see which method works b…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC
-
Scientists probe skin cells to unravel GVHD mystery
Knowledge-focused OngoingThis study looks at how different types of immune cells (dendritic cells) in the skin are involved in graft-versus-host disease (GVHD) after a bone marrow transplant. Researchers will collect skin samples and blood from 22 adults with acute or chronic skin GVHD to analyze cell ty…
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 18, 2026 12:12 UTC
-
Scientists probe why belly fat harms some but not others
Knowledge-focused OngoingThis study looks at why storing fat in and around organs like the liver affects some people's health more than others. Researchers will measure insulin sensitivity and inflammation in 144 lean and obese adults. The goal is to better understand these differences to help develop fu…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 18, 2026 12:10 UTC
-
Cancer consent study pulled before it even started
Knowledge-focused TerminatedThis study aimed to see if adding simple visual summaries to consent forms helps cancer patients better understand and feel less anxious about joining clinical trials. It was designed for adults with cancer who were already considering a trial. However, the study was withdrawn be…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 18, 2026 11:58 UTC
-
Brain wave clues may predict ECT success for depression
Knowledge-focused OngoingThis study looks at how electroconvulsive therapy (ECT) affects brain wave patterns in 31 adults with treatment-resistant depression. Researchers measure depression symptoms and brain activity during and after ECT sessions to find links. The goal is to better understand why ECT w…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC
-
Postpartum depression study pulled before it even started
Knowledge-focused TerminatedThis study was designed to see if combining ketamine injections with talk therapy could help low-income women with depressive symptoms after a C-section. The goal was to check if a larger future study was possible. However, the study was withdrawn before any participants were enr…
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC